Former Officials, Scholars Call Out Twisting of Patent Laws to Push Policy Agenda
WASHINGTON, Sept. 28, 2023 /PRNewswire/ -- In an effort organized by Adam Mossoff of the Hudson Institute's Forum for Intellectual Property, 25 of the nation's leading scholars, former judges, and former senior government officials sent a letter to U.S. senators correcting false claims that the federal government can use two patent laws, the Bayh-Dole Act and 28 U.S.C. § 1498, to impose price controls on prescription drugs.
"The Bayh-Dole Act and 28 U.S.C. § 1498 are not price-control laws," said Adam Mossoff, professor of law at the Antonin Scalia Law School at George Mason University. "Unfortunately, some academics and activists are attempting to distort the plain text of these laws to impose drug price controls. These efforts undermine the function of both statutes, which is to secure the patent protections critical to U.S. technological leadership and national security."
The 1980 Bayh-Dole Act gave universities and other research institutions the right to own and patent promising inventions made with the help of federal funding. The law has helped transform hundreds of university discoveries into life-improving products while supporting countless startups ranging from Google to biotech firms. As its namesake authors -- Senators Birch Bayh (D-Ind.) and Bob Dole (R-Kan.) -- have said, the law was never envisioned as a tool to set prices.
Congress passed 28 U.S.C. § 1498 over a century ago to resolve confusion in the courts concerning government use of patented inventions. The law says patent owners have a right to fair compensation if the government or a contractor violates their patent. Certain activists claim the law authorizes the government to direct any private company to infringe a patent. This blatantly contradicts the plain meaning of § 1498 and its interpretation by judges and government officials for over a century.
"Elected officials should not give airtime to these partisan theories, which have no basis in law or judicial precedent," said Mossoff. "A series of court decisions and policy missteps have significantly eroded the U.S. patent system in recent years, prompting much-needed reform efforts in Congress. It would be a mistake to further weaken the innovation incentives that drive the U.S. economy."
The letter signatories include:
Jonathan M. Barnett, Gould School of Law, University of Southern California
Honorable Susan G. Braden, U.S. Court of Federal Claims (Retired)
Daniel R. Cahoy, Pennsylvania State University
Honorable Ronald A. Cass, United States International Trade Commission (Former)
Honorable Walter G. Copan, Former Undersecretary of Commerce for Intellectual Property and Director National Institute of Standards and Technology
Richard A. Epstein, New York University School of Law
Stephen Ezell, Information Technology & Innovation Foundation
Bowman Heiden, University of California, Berkeley
Chris Holman, UMKC School of Law
Keith N. Hylton, Boston University School of Law
Justin (Gus) Hurwitz, University of Pennsylvania Carey Law School
Honorable Andrei Iancu, United States Patent & Trademark Office (Former)
Layne Keele, Samford University Cumberland School of Law
Adam MacLeod, St. Mary's University School of Law
Geoffrey A. Manne, International Center for Law & Economics
Damon C. Matteo, United States Patent & Trademark Office (Former)
Honorable Paul R. Michel, United States Court of Appeals for the Federal Circuit (Retired)
Emily Michiko Morris, University of Akron School of Law
Adam Mossoff, George Mason University
Honorable Kathleen M. O'Malley, United States Court of Appeals for the Federal Circuit (Retired)
Peter Pitts, Center for Medicine in the Public Interest
Aurelien Portuese, George Washington University
Kristen Osenga, University of Richmond School of Law
Honorable Randall R. Rader, United States Court of Appeals for the Federal Circuit (Retired)
Ted Sichelman, University of San Diego School of Law.
Expensify, Inc. , the financial management superapp for expenses and corporate cards, today announced that expense tracking for self-employed professionals is now available in its next-gen New Expensify platform. The upgrade makes it easier than ever...
FUTURE of SPACE is thrilled to announce that world-renowned Astrophysicist, Author, and Science Communicator Dr. Neil deGrasse Tyson, will join the stellar lineup of Featured Guests on the upcoming Space2Sea Voyage. Set to embark on a 10-day...
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce 63 students from 41 academic institutions have been selected to take part in the 2024 NIIMBL eXperience, the largest cohort since the Program's...
The Board of Directors of S&P Global has approved a cash dividend on the Corporation's common stock for the second quarter of 2024. The dividend of $0.91 is payable on June 12, 2024, to shareholders of record on May 29, 2024. The annualized dividend...
Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:
Today the FDA, in coordination with the U.S. Department of Justice (DOJ), announced that the U.S. Marshals Service seized unauthorized...
Hawcx, a pioneer in Intelligent passwordless authentication, marks a significant milestone with the launch of its cutting-edge platform. The platform, designed to revolutionize authentication for both enterprises and end-users, offers a seamless...